Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jack. H. Ladenson

Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease

English

Related publications

Assessment of Cerebrospinal Fluid Neurogranin as a Predictor of Alzeheimer’s Disease Through Synaptic Dysfunction

International Journal of Neurosurgery

English

Cerebrospinal Fluid Neurogranin and YKL-40 as Biomarkers of Alzheimer's Disease

Annals of Clinical and Translational Neurology

English

APLP1 as a Cerebrospinal Fluid Biomarker for Γ-Secretase Modulator Treatment

Alzheimer's Research and Therapy

Cognitive Neuroscience

English

Electroconvulsive Therapy Does Not Alter the Synaptic Protein Neurogranin in the Cerebrospinal Fluid of Patients With Major Depression

Journal of Neural Transmission

Biological Psychiatry

English

The Amyloid-Β Oligomer Count in Cerebrospinal Fluid Is a Biomarker for Alzheimer's Disease

Journal of Alzheimer's Disease

Clinical Psychology

English

Cerebrospinal Fluid P-Tau217 Performs Better Than P-Tau181 as a Biomarker of Alzheimer’s Disease

Nature Communications

Molecular Biology

English

Associations Between Cerebral Small-Vessel Disease and Alzheimer Disease Pathology as Measured by Cerebrospinal Fluid Biomarkers

English

Synaptic Actin Stabilization Protein Loss in Down Syndrome and Alzheimer Disease

Brain Pathology

Forensic Medicine

English

Integrated Proteomics Reveals Brain-Based Cerebrospinal Fluid Biomarkers in Asymptomatic and Symptomatic Alzheimer's Disease

English